Evidence map›Paper›PMID 41728440›Full record

ReviewCureus2026

Epidemiological Landscape of Breast Cancer in Northern India: A Narrative Review of Jammu and Kashmir.

Gita Devi, Mittal Rathod, Mehul Kaliya, Aneri Rathod

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gita DeviRadiodiagnosis, All India Institute Of Medical Science, Jammu, IND.
Mittal RathodCommunity Medicine, Pandit Deendayal Upadhyay Government Medical College, Rajkot, IND.
Mehul KaliyaMedicine, All India Institute Of Medical Science, Rajkot, IND.
Aneri RathodSurgical Oncology, Gujarat Cancer Research Institute, Ahmedabad, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is increasingly affecting younger women across India, with the Union Territory (UT) of Jammu and Kashmir (J&K) experiencing a similar shift. Limited regional data and poor screening access contribute to late diagnosis and high psychosocial burden, necessitating a synthesized evaluation of existing evidence. The objective of this review is to summarize and critically appraise the published literature on breast cancer in Jammu and Kashmir, with a specific focus on its epidemiology, clinical characteristics, molecular subtype distribution, awareness levels, and psychosocial determinants. A narrative review approach was adopted. Studies published in English and conducted within J&K were searched through PubMed, MEDLINE, and Google Scholar. Eligible studies included those reporting epidemiology, staging, molecular patterns, risk awareness, and mental-health outcomes. Data were extracted and synthesized according to the study characteristics. A total of 12 studies were included. Findings revealed a younger pattern of onset, with most cases detected between the late 30s and early 60s. Late-stage presentation (≥ stage III) was predominant, especially in Kashmir. Infiltrating ductal carcinoma and HR+/HER2- subtype were the most common. Awareness and screening rates were low, particularly among women >40 years. High levels of depression, anxiety, and post-traumatic stress disorder (PTSD) were reported among patients in Jammu. Mobile mammography initiatives showed high feasibility but poor follow-up linkage. Breast cancer in J&K is characterized by late diagnosis, distinct molecular patterns, limited awareness, and high psychological burden. Strengthening community-level screening, establishing population-based cancer registries, expanding mobile mammography programs, and integrating psycho-oncology into cancer care are crucial for improving early detection and outcomes in the UT.

Indexed as

breast cancerepidemiologyjammu and kashmirmobile mammographymolecular subtypepsychological morbidityscreening

Identifiers

PMID41728440
PMCPMC12921269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.